Speaker Details

Joel M. Gelfand, MD, MSCE, FAAD

Joel M. Gelfand, MD, MSCE, FAAD

SESSIONS

S018 Psoriasis
Mar 8, 2024 1:00 PM - 4:00 PM Room 20B
S017 Great Care for Common Conditions: Combining Evidence and Cost Effectiveness
Mar 8, 2024 1:00 PM - 4:00 PM Room 2
S026 Late-breaking Research: Session 1
Mar 9, 2024 9:00 AM - 12:00 PM Room 20B
S050 Late-Breaking Research: Session 2
Mar 10, 2024 1:00 PM - 4:00 PM Room 20B
S058 Psoriasis: Modern Therapeutic Approaches
Mar 11, 2024 9:00 AM - 12:00 PM Room 6A

HANDOUTS

Login to view handouts

DISCLOSURES

AbbVie – Consultant(Fees); Abcentra – Consultant(Fees); Amgen – Investigator(Grants/Research Funding); Artax Biopharma – Data Safety Monitoring Board(Fees); BMS – Consultant(Fees); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); CellDex – Data Safety Monitoring Board(Fees); Daavlin Company – Other(Equipment); FIDE – Consultant(Fees); GlaxoSmithKline – Consultant(Honoraria); Happify – Consultant(Fees); Healio – Other(Fees); Imagine – Data Safety Monitoring Board(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Fees); Mindera – Consultant(Fees); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neumentum, Inc. – Consultant(Fees); Neuroderm LTD – Other(Fees); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Other(Fees); Veolia North America – Consultant(Fees);